← Leaderboards
Floyd J Thompson
University Of Florida
$1,178,236
Attributed
$1,178,236
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $301.4K · FY2005–24$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,178,236 · 1
VA$0 · 4
By mechanism
R01$1,178,236 · 1
I01$0 · 3
I21$0 · 1
Top collaborators
- Prodip K. Bose15 shared
Most similar at University Of Florida
Same institution · by research overlap
- Charles E Wood$10,365,562
- Michael Aron Lane$3,021,942
- Karen W Hegland$3,354,195
- James H Cauraugh$143,390
- John G Burleigh$667,659
Others in their field
Top investigators on “Injury”
- Polly Chang · Sri International$119,352,977
- Marco Pahor · Wake Forest University Health Sciences$82,312,292
- Kerry J Kelly · New York City Fire Department$81,924,266
- Asrar B. Malik · University Of Illinois At Chicago$81,164,529
- Peter Scott Heeger · Case Western Reserve University$76,259,223
- Jacqueline Moline · Icahn School Of Medicine At Mount Sinai$75,762,106
Research focus
InjuryChronicNoradrenergicVeteransTranslationsDisabilityTreatment EfficacySafety TestingNeurobiologyHealthcare SystemsExerciseBehavioralOutcome MeasureGaitAnimalsBaseNeurologicReportingSafetyHeadInflammationPainBehaviorImmune
Grant awards (20)
Efficacy and safety of a new hexadentate iron chelator therapy for TBI-induced chronic disabilities in a rodent model$0
I01 · FY2024 · VA
Feasibility of Using PET Imaging for Detection of Treatment-Induced Changes in Chronic Neuroinflammation Following TBI$0
I21 · FY2023 · VA · contact PI
Efficacy and safety of a new hexadentate iron chelator therapy for TBI-induced chronic disabilities in a rodent model$0
I01 · FY2022 · VA
Efficacy and safety of a new hexadentate iron chelator therapy for TBI-induced chronic disabilities in a rodent model$0
I01 · FY2022 · VA
Efficacy and safety of a new hexadentate iron chelator therapy for TBI-induced chronic disabilities in a rodent model$0
I01 · FY2020 · VA
Efficacy and safety of a new hexadentate iron chelator therapy for TBI-induced chronic disabilities in a rodent model$0
I01 · FY2019 · VA
Therapeutic potential of combined locomotor training and TMS in SCI$0
I01 · FY2018 · VA
Therapeutic potential of combined locomotor training and TMS in SCI$0
I01 · FY2017 · VA
Therapeutic potential of combined locomotor training and TMS in SCI$0
I01 · FY2016 · VA
Therapeutic potential of combined locomotor training and TMS in SCI$0
I01 · FY2016 · VA
Neurobiology and Experimental Treatment of TBI Pain and Anxiety$0
I01 · FY2016 · VA · contact PI
Neurobiology and Experimental Treatment of TBI Pain and Anxiety$0
I01 · FY2015 · VA · contact PI
Neurobiology and Experimental Treatment of TBI Pain and Anxiety$0
I01 · FY2014 · VA · contact PI
Therapeutic potential of combined locomotor training and TMS in SCI$0
I01 · FY2014 · VA
Neurobiology and Experimental Treatment of TBI Pain and Anxiety$0
I01 · FY2014 · VA · contact PI
Neurobiology and Experimental Treatment of TBI Pain and Anxiety$0
I01 · FY2012 · VA · contact PI
Neurophysiology of Spinal Cord Injury and Treatment$285,773
R01 · FY2007 · NS · contact PI
Neurophysiology of Spinal Cord Injury and Treatment$294,308
R01 · FY2006 · NS · contact PI
Neurophysiology of Spinal Cord Injury and Treatment$301,433
R01 · FY2005 · NS
Neurophysiology of Spinal Cord Injury and Treatment$296,722
R01 · FY2004 · NS